Dr. Mazen Noureddin from Houston Methodist Underwood Center for Digestive Health presents at ACG 2025 on pioneering therapies for MASLD, evaluating GLP-1 in phase 3 trials, and highlighting a multidisciplinary approach that aims for a synergistic effect in clinical practice.